ATI-2138

· Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-2138, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]